Webcast
Tuesday, May 17, 2022 at 9 AM EDT|6am PDT|2pm BST|3pm CEST Tuesday, May 17, 2022 at 2 PM EDT|11am PDT|7pm BST|8pm CEST Increase productivity and reduce costs for mAb purification. Learn how multi-column continuous chromatography can improve your mAb purification workflow.
Register Free: https://www.biopharminternational.com/bp_w/multi_col
Event Overview:
Multi-column continuous chromatography (MCC) represents the newest technology for increased productivity in downstream purification. MCC offers significant productivity and economic advantages over traditional batch methods particularly for the purification of monoclonal antibodies (mAbs).
Key Learning Objectives:
Who Should Attend:
Speakers
J. Kevin O’Donnell, PhD.
R&D Manager – Chromatography Column Technologies
Tosoh Bioscience LLC
Kevin O’Donnell obtained his doctorate degree from Temple University. After a post-doctoral position in the Department of Molecular Genetics at SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline), Kevin moved to DNX where he worked on the expression of human hemoglobins in transgenic animals. For the past 26 years Kevin has been a member of the Technical Service and Research and Development teams at Tosoh Bioscience. Currently, Kevin is the R&D Manager of Chromatography Column Technologies at Tosoh Bioscience. He focuses on the development of new product technologies to optimize purification of biological samples and is developing multi-column continuous chromatography processes.
Register Free: https://www.biopharminternational.com/bp_w/multi_col